An OpenAI Researcher Is Leaving to Chase Drug Discovery. Investors Already Value It at $2 Billion

Miles Wang, an OpenAI researcher whose work focused on using AI to accelerate scientific and biological discovery, is leaving the company to launch his own drug-discovery startup, according to people…

NewsTrackerToday

NewsTrackerToday is an international analytical media platform offering a deep and independent view of the events shaping the global economy, business, and technology landscape. We don’t just cover the news – we analyze the forces behind it.

Our team unites experienced journalists and analysts specializing in economics, finance, corporate strategy, and global markets. Every article is based on verified data, independent research, and professional expertise.

At NewsTrackerToday, accuracy, objectivity, and analytical depth come first. We identify trends, forecast shifts, and provide readers with tools to make informed decisions in an unpredictable environment.

Our core focus areas include macroeconomics, business, technology, and investments. We track how global trends influence local markets, industries, and individual investors.

NewsTrackerToday is more than media – it’s a reliable compass in an ever-changing information world.

Top News

AI Under Fire: OpenAI Faces Probe Over Deadly ChatGPT Link

Florida authorities have launched an investigation into OpenAI following allegations that its chatbot technology played a role in a deadly…

EV Batteries No Longer Needed? Startup Shifts to Military Tech

Sion Power’s strategic shift from electric vehicles to defense and aerospace applications…

The U.S. Just Quietly Cleared More Chinese Firms to Buy Nvidia’s H200. ZTE Is One of Them.

A unit of telecoms equipment maker ZTE and two other Chinese firms…

McDonald’s Overpriced? The Shocking Truth Behind the Numbers

For decades, investors have treated McDonald's as one of the market’s most…

AI Power Clash: Cohere’s Bold European Grab Shakes Tech Sovereignty Battle

Cohere is moving to acquire Aleph Alpha in a deal aimed at…